Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-16

FDA Approved: NITROFURANTION — Original Application (BluePoint Labortories)

View source ↗

Summary

The FDA approved the Original Application (ANDA201722) for NITROFURANTION by BluePoint Labortories, authorizing its marketing as a generic drug. This marks the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROFURANTION (NITROFURANTION)

Snippet

ORIG AP for NITROFURANTION (NITROFURANTION)